Cite
Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression
MLA
Misha C. Tran, et al. “Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression.” Clinical Lung Cancer, vol. 24, May 2023, pp. e117–21. EBSCOhost, https://doi.org/10.1016/j.cllc.2023.01.003.
APA
Misha C. Tran, Garth W. Strohbehn, Theodore G. Karrison, Sherin J. Rouhani, Jeremy P. Segal, Ardaman Shergill, Philip C. Hoffman, Jyoti D. Patel, Marina C. Garassino, Everett E. Vokes, & Christine M. Bestvina. (2023). Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression. Clinical Lung Cancer, 24, e117–e121. https://doi.org/10.1016/j.cllc.2023.01.003
Chicago
Misha C. Tran, Garth W. Strohbehn, Theodore G. Karrison, Sherin J. Rouhani, Jeremy P. Segal, Ardaman Shergill, Philip C. Hoffman, et al. 2023. “Brief Report: Discordance Between Liquid and Tissue Biopsy-Based Next-Generation Sequencing in Lung Adenocarcinoma at Disease Progression.” Clinical Lung Cancer 24 (May): e117–21. doi:10.1016/j.cllc.2023.01.003.